AAAAAA
Results:
1-15
|
Results: 15
Authors:
SPERBER K
SHIM J
MEHRA M
LIN A
GEORGE I
OGATA S
MAYER L
ITZKOWITZ S
Citation: K. Sperber et al., MUCIN SECRETION IN INFLAMMATORY BOWEL-DISEASE - COMPARISON OF A MACROPHAGE-DERIVED MUCIN SECRETAGOGUE (MMS-68) TO CONVENTIONAL SECRETAGOGUES, Inflammatory bowel diseases, 4(1), 1998, pp. 12-17
LIGHTING MARKET OPPORTUNITIES - RECONCILING CONSUMERS PURCHASING BEHAVIORS WITH ENVIRONMENTAL VALUES
Authors:
CONWAY KM
MEHRA M
Citation: Km. Conway et M. Mehra, LIGHTING MARKET OPPORTUNITIES - RECONCILING CONSUMERS PURCHASING BEHAVIORS WITH ENVIRONMENTAL VALUES, Journal of the Illuminating Engineering Society, 27(2), 1998, pp. 67
Authors:
MEHRA R
ZEHRA N
MEHRA M
Citation: R. Mehra et al., DEVELOPMENT OF ELISA METHODS FOR THE SEMIQUANTITATIVE MEASUREMENT OF EPSTEIN-BARR-VIRUS IGG AND IGM IN HUMAN SERUM USING A SINGLE REAGENT TMB SUBSTRATE, Clinical chemistry, 44, 1998, pp. 31-31
Authors:
KUMAR A
MEHRA M
BADHAN SK
GULATI N
Citation: A. Kumar et al., HETEROSEXUAL BEHAVIOR AND CONDOM USAGE IN AN URBAN-POPULATION OF DELHI, INDIA, AIDS care, 9(3), 1997, pp. 311-318
Authors:
SASTRY A
FLYNN K
MEHRA M
Citation: A. Sastry et al., DEVELOPMENT OF AN ELISA METHOD FOR THE MEASUREMENT OF HELICOBACTER-PYLORI IN HUMAN SERUM USING A SINGLE REAGENT TMB SYSTEM, Clinical chemistry, 43, 1997, pp. 628-628
Authors:
HOLMES RR
MEHRA M
Citation: Rr. Holmes et M. Mehra, DEVELOPMENT AND CLINICAL VALIDATION OF A 90 MINUTE MEASLES IGG ELISA KIT USING A SINGLE LIQUID REAGENT TMB SUBSTRATE, Clinical chemistry, 43, 1997, pp. 629-629
Authors:
MAHESHWARI R
MEHRA M
Citation: R. Maheshwari et M. Mehra, VALIDATION OF ANA ELISA METHOD USING TMB AS A SINGLE SUBSTRATE REAGENT, Clinical chemistry, 41(6), 1995, pp. 63-63
Authors:
FAZAL N
MANI A
MEHRA M
Citation: N. Fazal et al., THE STABILIZATION OF A LIQUID PNPP SINGLE-SUBSTRATE REAGENT, Clinical chemistry, 41(6), 1995, pp. 81-81
Authors:
JACOTOT B
BANGA JD
PFISTER P
MEHRA M
Citation: B. Jacotot et al., EFFICACY OF A LOW DOSE-RANGE OF FLUVASTATIN (XU-62-320) IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - A DOSE-RESPONSE STUDY IN 431 PATIENTS, British journal of clinical pharmacology, 38(3), 1994, pp. 257-263
Authors:
PETERS TK
MURATTI EN
MEHRA M
Citation: Tk. Peters et al., EFFICACY AND SAFETY OF FLUVASTATIN IN WOMEN WITH PRIMARY HYPERCHOLESTEROLEMIA, Drugs, 47, 1994, pp. 64-72
Authors:
PETERS TK
MURATTI EN
MEHRA M
Citation: Tk. Peters et al., FLUVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA - EFFICACY AND SAFETY IN PATIENTS AT HIGH-RISK - AN ANALYSIS OF A CLINICAL-TRIAL DATABASE, The American journal of medicine, 96, 1994, pp. 190000079-190000083
Authors:
BANGA JD
JACOTOT B
PFISTER P
MEHRA M
Citation: Jd. Banga et al., LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIA WITH FLUVASTATIN - A 52-WEEK MULTICENTER SAFETY AND EFFICACY STUDY, The American journal of medicine, 96, 1994, pp. 190000087-190000093
Authors:
LARK BS
MEHRA M
Citation: Bs. Lark et M. Mehra, CORRELATION BETWEEN TOPOLOGICAL FEATURES AND EXCESS COMPRESSIBILITIESOF SOME ARENE BINARY-MIXTURES, Acustica, 80(2), 1994, pp. 178-180
Authors:
PETERS TK
MEHRA M
MURATTI EN
Citation: Tk. Peters et al., EFFICACY AND SAFETY OF FLUVASTATIN IN HYPERTENSIVE PATIENTS - AN ANALYSIS OF A CLINICAL-TRIAL DATABASE, American journal of hypertension, 6(11), 1993, pp. 190000340-190000345
Authors:
PETERS TK
JEWITTHARRIS J
MEHRA M
MURATTI EN
Citation: Tk. Peters et al., SAFETY AND TOLERABILITY OF FLUVASTATIN WITH CONCOMITANT USE OF ANTIHYPERTENSIVE AGENTS - AN ANALYSIS OF A CLINICAL-TRIAL DATABASE, American journal of hypertension, 6(11), 1993, pp. 190000346-190000352
Risultati:
1-15
|